Clinical trials
Recruiting Phase 1 Leukemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 9 |
| 2025 | 5 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dana-Farber Cancer Institute | 4 |
| Kura Oncology, Inc. | 2 |
| Stanford University | 2 |
| Affiliated Hospital of Nantong University | 1 |
| Allterum Therapeutics, Inc | 1 |
| Baylor College of Medicine | 1 |
| Beijing 302 Hospital | 1 |
| Beijing GoBroad Hospital | 1 |
| BlossomHill Therapeutics | 1 |
| Charm Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 39 |
| Leukemia, Myeloid, Acute | 20 |
| Leukemia, Myeloid | 7 |
| Lymphoma | 7 |
| Hematologic Neoplasms | 6 |
| Myelodysplastic Syndromes | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Recurrence | 6 |
| Burkitt Lymphoma | 4 |
| Leukemia, Myelomonocytic, Juvenile | 2 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.